Nightingale Health Oyj Statistics
Total Valuation
HEL:HEALTH has a market cap or net worth of EUR 183.46 million. The enterprise value is 125.45 million.
Market Cap | 183.46M |
Enterprise Value | 125.45M |
Important Dates
The last earnings date was Thursday, March 6, 2025.
Earnings Date | Mar 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HEL:HEALTH has 60.35 million shares outstanding. The number of shares has increased by 0.00% in one year.
Current Share Class | n/a |
Shares Outstanding | 60.35M |
Shares Change (YoY) | +0.00% |
Shares Change (QoQ) | +1.93% |
Owned by Insiders (%) | 28.24% |
Owned by Institutions (%) | 7.48% |
Float | 34.82M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 37.05 |
PB Ratio | 2.42 |
P/TBV Ratio | 2.83 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -7.32 |
EV / Sales | 25.34 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -12.67 |
Financial Position
The company has a current ratio of 12.46, with a Debt / Equity ratio of 0.02.
Current Ratio | 12.46 |
Quick Ratio | 12.21 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | -0.17 |
Interest Coverage | -55.73 |
Financial Efficiency
Return on equity (ROE) is -20.65% and return on invested capital (ROIC) is -13.43%.
Return on Equity (ROE) | -20.65% |
Return on Assets (ROA) | -12.91% |
Return on Invested Capital (ROIC) | -13.43% |
Return on Capital Employed (ROCE) | -24.20% |
Revenue Per Employee | 52,670 |
Profits Per Employee | -182,298 |
Employee Count | 86 |
Asset Turnover | 0.06 |
Inventory Turnover | 1.56 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +192.31% in the last 52 weeks. The beta is 0.60, so HEL:HEALTH's price volatility has been lower than the market average.
Beta (5Y) | 0.60 |
52-Week Price Change | +192.31% |
50-Day Moving Average | 2.90 |
200-Day Moving Average | 2.85 |
Relative Strength Index (RSI) | 50.76 |
Average Volume (20 Days) | 76,846 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HEL:HEALTH had revenue of EUR 4.95 million and -17.14 million in losses. Loss per share was -0.28.
Revenue | 4.95M |
Gross Profit | 3.60M |
Operating Income | -18.39M |
Pretax Income | -17.07M |
Net Income | -17.14M |
EBITDA | -15.28M |
EBIT | -18.39M |
Loss Per Share | -0.28 |
Balance Sheet
The company has 59.71 million in cash and 1.70 million in debt, giving a net cash position of 58.01 million or 0.96 per share.
Cash & Cash Equivalents | 59.71M |
Total Debt | 1.70M |
Net Cash | 58.01M |
Net Cash Per Share | 0.96 |
Equity (Book Value) | 75.66M |
Book Value Per Share | 1.25 |
Working Capital | 57.08M |
Cash Flow
In the last 12 months, operating cash flow was -8.36 million and capital expenditures -1.54 million, giving a free cash flow of -9.90 million.
Operating Cash Flow | -8.36M |
Capital Expenditures | -1.54M |
Free Cash Flow | -9.90M |
FCF Per Share | -0.16 |
Margins
Gross Margin | 72.77% |
Operating Margin | -371.46% |
Pretax Margin | -344.80% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
HEL:HEALTH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.00% |
Shareholder Yield | -0.00% |
Earnings Yield | -9.34% |
FCF Yield | -5.40% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HEL:HEALTH has an Altman Z-Score of 13.67.
Altman Z-Score | 13.67 |
Piotroski F-Score | n/a |